Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Toxicity (ADMET, symbol 2)
[{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c15/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c15/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c16/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c16/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c17/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c17/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c18/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c18/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c19/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c19/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1a/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1a/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1b/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1b/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1c/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1c/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1d/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1d/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1e/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1e/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c1f/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c1f/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c20/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c20/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c21/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c21/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c22/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c22/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c23/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c23/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c24/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c24/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c25/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c25/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c26/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c26/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c27/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c27/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c28/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c28/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c29/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c29/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2a/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2a/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2b/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2b/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2c/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2c/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2d/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2d/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2e/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2e/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c2f/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c2f/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c30/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c30/67f5958c8036a7aacbd4d2a0.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/67f595b5caf26851ae3a2c31/67f5958c8036a7aacbd4d2a0.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/67f595b5caf26851ae3a2c31/67f5958c8036a7aacbd4d2a0.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
admet,absorption,Distribution,Metabolism,Excretion
Toxicity,drug discovery,drug development,toxicology,pharmacokinetics,drug candidate,drug assessment,drug distribution,drug toxicity,toxicology,drug safety,adverse drug reaction,toxic dose,drug overdose,cytotoxicity,hepatotoxicity,nephrotoxicity,neurotoxicity,dose-limiting toxicity,therapeutic index,toxicology screening,safety pharmacology,drug-induced toxicity,off-target toxicity,cell toxicity,organ toxicity,clinical toxicology,preclinical toxicology,toxicological assessment,toxicity testing,toxicity evaluation,toxic effect,toxicity modeling,toxicity biomarkers,toxic compound,toxicity prediction,toxicogenomics,toxicology profile,schematic,symbol,symbolic,sign,icon,iconography,mark,signify,simple,content-refinement-AI-expansion,admet,absorption,drug discovery
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
